Browse Category

LSE:LLOY.L News 8 January 2026 - 6 February 2026

NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest shares rose 0.7% to 654.6 pence early Friday, recovering some ground after a 6% drop Thursday triggered by the Bank of England’s split vote on rates. The BoE kept its rate at 3.75% but signaled possible cuts ahead. NatWest repurchased over 800,000 shares this week and will release annual results next Friday.
Lloyds share price near 106p after BoE close vote stirs rate-cut bets

Lloyds share price near 106p after BoE close vote stirs rate-cut bets

Lloyds Banking Group shares hovered near 105.8 pence Friday after dropping 5.6% Thursday, following the Bank of England’s decision to keep rates at 3.75%. The bank bought back 7 million shares on Feb. 5 at an average 106.86 pence. UK bank stocks fell as the FTSE 100 slipped 0.9%. Investors now focus on the Bank of England’s March 19 meeting for signals on rate cuts.
Lloyds share price jumps toward a fresh high as corporate banking push report lands

Lloyds share price jumps toward a fresh high as corporate banking push report lands

Lloyds shares rose 1.4% to 114.2 pence in early London trading, approaching a 52-week high, after reports of a planned expansion into corporate banking. Deutsche Bank raised its target price to 125 pence, keeping a buy rating, while Shore Capital downgraded Lloyds to sell. The bank bought back nearly 3 million shares on Tuesday. Lloyds recently posted a 12% rise in 2025 pre-tax profit to £6.7 billion.
4 February 2026
Lloyds share price hits fresh 52-week high as buyback starts — what to watch next week

Lloyds share price hits fresh 52-week high as buyback starts — what to watch next week

Lloyds Banking Group shares closed Friday at 108.95 pence, up 3.32% to a 52-week high, after launching a £1.75 billion buyback and raising its 2026 profitability target. The bank reported a 12% rise in 2025 pre-tax profit to £6.7 billion. Lloyds bought 10 million shares Friday for cancellation. Investors await the Bank of England’s rate decision Feb. 5 and Lloyds’ annual report Feb. 18.
31 January 2026
Lloyds share price rises as £1.75bn buyback begins — motor finance risk back in focus

Lloyds share price rises as £1.75bn buyback begins — motor finance risk back in focus

Lloyds Banking Group shares rose 1.2% to 106.7 pence after launching a £1.75 billion buyback program on Friday. The bank set aside £1.95 billion for motor finance provisions and recommended a 2.43 pence final dividend. Lloyds reported a 12% rise in 2025 profit before tax to £6.7 billion and raised its 2026 profitability target to over 16% return on tangible equity.
Lloyds (LLOY.L) share price jumps on profit beat and £1.75bn buyback — what investors watch next

Lloyds (LLOY.L) share price jumps on profit beat and £1.75bn buyback — what investors watch next

Lloyds shares rose 2.2% to a 52-week high after the bank announced a £1.75 billion buyback and raised its 2026 profit target. Annual pre-tax profit jumped 12% to £6.7 billion, beating forecasts. The bank increased its dividend and projected 2026 net interest income at about £14.9 billion. Uncertainty remains over motor finance compensation costs.
FTSE 100 rises as miners lift London stocks; 3i soars, Lloyds upgrades targets

FTSE 100 rises as miners lift London stocks; 3i soars, Lloyds upgrades targets

London’s FTSE 100 rose 0.44% to 10,198.75 by 1105 GMT, led by mining and financial stocks. Gold surged near $5,600 an ounce, hitting new highs as investors sought safe havens amid geopolitical tensions and a weaker dollar. 3i Group jumped 14% after strong results from Action, while Lloyds gained 0.5% on a profit beat and new share buyback. Sterling hovered near multi-year highs against the dollar.
Lloyds share price edges up after profit beat, bigger buyback and fresh 2026 targets

Lloyds share price edges up after profit beat, bigger buyback and fresh 2026 targets

Lloyds Banking Group shares rose 0.6% after the bank beat profit forecasts, raised its outlook, and announced a £1.75 billion share buyback. The lender set aside £968 million for motor finance remediation, warning this will impact full-year results. The board raised the final dividend to 2.43 pence per share. Return on tangible equity reached 12.9%, or 14.8% excluding the motor finance charge.
29 January 2026
Lloyds Banking Group share price lifts as profit-target talk grows ahead of results

Lloyds Banking Group share price lifts as profit-target talk grows ahead of results

Lloyds Banking Group shares rose 0.6% to 102.30 pence in early London trading Monday ahead of its full-year results due Thursday. Trading volume reached 92.6 million shares by 0855 GMT. Investors are watching for guidance on profit targets, net interest margin, and possible capital returns as UK banks signal higher earnings ambitions. CEO Charlie Nunn and CFO William Chalmers will brief investors at 0930 GMT.
HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC shares closed up 0.55% at 1,238.8 pence in London, near a 52-week high. The FTSE 100 fell 0.4% after new U.S. tariff threats hit European markets. HSBC confirmed a 6.13% stake in International Personal Finance and set Jan. 23 for a Hong Kong court hearing on Hang Seng Bank’s privatisation. Investors await HSBC’s annual results on Feb. 25.
Lloyds share price dips as Trump’s credit-card cap rattles bank stocks

Lloyds share price dips as Trump’s credit-card cap rattles bank stocks

Lloyds Banking Group shares fell 0.2% to 100.1 pence in early London trading Monday, tracking a wider decline in European bank stocks after the U.S. announced a cap on credit-card interest rates. Barclays dropped 4.5%, HSBC slipped 1%. Lloyds will report preliminary 2025 results on Jan. 29. The bank is also considering raising CEO Charlie Nunn’s maximum pay to £13.2 million, per The Guardian.
12 January 2026
Lloyds Banking Group stock near £1: CEO pay shake-up hits headlines as buyback bets build

Lloyds Banking Group stock near £1: CEO pay shake-up hits headlines as buyback bets build

Lloyds is preparing a new pay policy that could raise CEO Charlie Nunn’s maximum award to £13.2 million, the Guardian reported. Shareholders will vote on the plan at the annual meeting, as peers have also lifted pay ceilings. Lloyds shares closed at 100.30p Friday, near a 52-week high. Investors await the bank’s Jan. 29 results for updates on dividends, buybacks, and motor finance redress.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop